itinai content

  • AI News
  • AI Sales
  • Apple AI
  • Biohacking
  • Clinical Trials
  • Compare
  • Computer Vision
  • DeepSense
  • farma
  • Instruments
  • Management
  • Marketing
  • Marktechpost
  • Open AI
  • resume
  • КП
  • Family Offices Are Becoming a Force in Capital Markets

    7 ноября, 2026

    What happens when the focus of the family business becomes … other businesses?  After building wealth through their primary enterprise, a growing number of family offices are now looking to invest directly in other businesses. Kellogg’s Matt Allen and Jose Liberti have labeled this approach “legacy equity”—an investment model that resembles private equity but with… →

    Management
  • Are Attitudes Toward Others Taking a U-Turn?

    7 ноября, 2026

    If you’d looked at surveys of Americans’ attitudes five years ago, you would have seen a hopeful story.  Biases against people based on their race, sexual orientation, and disability were consistently dropping across the country, says Tessa Charlesworth, an assistant professor of management and organizations at the Kellogg School. This included both explicitly stated bias… →

    Management
  • What’s the Cost of an NFL Injury?

    7 ноября, 2026

    When NFL quarterback Jalen Hurts was ruled out for the season due to dangerous blood clots, fans of the Philadelphia Eagles were quick to write off the team’s chances.   It’s a common refrain among football fans: we could’ve been contenders if it weren’t for the injuries.  But the impact of injuries on NFL teams is… →

    Management
  • Take 5: On the Neverending Campaign Trail

    7 ноября, 2026

    We live in the era of the constant political campaign. As soon as the votes are tallied and the winners declared in one election, pundits crank up the speculation on the candidates’ prospects for the next one.   Researchers at the Kellogg School keep an eye on political campaigns as well, studying everything from the… →

    Management
  • Effects of intradermal lymphocyte therapy in patients with recurrent pregnancy loss: secondary analysis of a randomized controlled trial investigating purinergic signaling, inflammation, and cellular energy status

    7 ноября, 2026

    CONCLUSION: Low-dose ILT may be associated with improved successful pregnancy and live birth rates in RPL patients. These clinical outcomes coincided with changes in purinergic signaling, inflammatory cytokines, and cellular energy status; however, formal mediation cannot be inferred from the present analysis. →

    Clinical Trials
  • LEgal Guidance for Cancer Patients and CAREgivers (LEGACY CARE): A Pilot Clinical Trial

    6 ноября, 2026

    CONCLUSIONS: Proactive legal care for recently diagnosed patient-caregiver dyads was feasible and acceptable, and identified and addressed HHLNs. However, caregiver-inclusive medical-legal partnership models may require caregiver-specific intake, longitudinal follow-up, and clearer distinction between patient, caregiver, and shared needs. →

    Clinical Trials
  • In-the-Bag Stability of a New Hydrophilic Acrylic Toric Intraocular Lens

    6 ноября, 2026

    CONCLUSIONS: Although mean absolute tilt and decentration values were low, in some cases, a pronounced tilt and posterior axial hyperopic shift occurred. Excessive anterior fibrosis development was responsible for these changes. →

    Clinical Trials
  • Therapeutic plasma exchange improves survival in alcohol-related acute-on-chronic liver failure: a randomized controlled trial

    6 ноября, 2026

    CONCLUSION: PLEX improves short-term survival and disease severity in A-ACLF and may be a valuable therapeutic option where transplantation is limited. →

    Clinical Trials
  • Establishment of reference ranges for disturbance coefficient (DC) and edema coefficient (EC) in neonates: a non-invasive cerebral edema monitoring study

    6 ноября, 2026

    CONCLUSIONS: In neonates over 36 weeks, DC significantly increased from 0-1 day to 1-2 and 2-3 days after birth, while EC decreased. DC showed a positive correlation with head circumference, weight, and body length, while EC exhibited a negative correlation. DC and EC were not affected by sex, mode of delivery, and gestational age. →

    Clinical Trials
  • Cost-effectiveness of onabotulinumtoxinA versus topiramate in chronic migraine in the US: an economic analysis of the FORWARD randomized trial

    6 ноября, 2026

    CONCLUSION: OnabotA was a cost-effective preventive treatment of chronic migraine versus topiramate. Although OnabotA had higher drug acquisition costs, these were offset by reduced HCRU costs due to fewer migraines, resulting in a low incremental cost per headache-day avoided versus topiramate. →

    Clinical Trials
1 2 3 … 1 069
Следующая страница